Clinical Research Nurse, London, UK Jan-2013
PhD student position, Tübingen, Germany
The Department of Medical Genetics at the University of Tuebingen (Head Prof. Dr. O. Riess) announces a
PhD student position
starting on or before Nov. 1, 2012.phd_student-tübingen
The student will work on a three year project funded by the research programme ’Internationale Spitzenforschung II-3’ of the Baden-Wuerttemberg foundation. The research project is centred on the pharmacological inhibition of Caspase-6 as a therapeutic target in Huntington Disease and the role of calpains in the pathogenesis of Huntington Disease. The experiments will be done in vitro (cell culture) and in vivo (animal models).The project will be done in close collaboration with the lab of Prof. Dr. Michael Hayden at the University of British Columbia in Vancouver, Canada. Regular meetings to be held twice a year will rotate between Tuebingen and Vancouver.
The successful candidate should be able to perform standard cellular biology techniques on their own such as DNA preparation, PCR, quantitative PCR, sequencing, protein isolation, Western Blots, and immunohistochemistry. Previous experience in animal work, especially behavioural studies, is desirable.
We offer intensive training and a positive working environment in a young team. We are looking for someone who is committed and works well in a group.
The student will be employed by the University Hospital of Tuebingen. Salary will be based on the TVö (E13/2) structure. For more information please contact us directly.
Please send your application before September 30th to
Dr. Huu Phuc Nguyen
Department of Medical Genetics
University Hospital of Tuebingen
Phone: +49 7071 29 72296
Clinical Fellowship in Huntington’s Disease Research at UBC, Vancouver, Canada - March 2012
is an innovative multi-centre, multi-national prospective observational study with no experimental treatment that follows the successful previous clinical study TRACK-HD. The primary objective of TRACK-HD was to determine what combination of measures is the most sensitive for detecting change over the natural course of premanifest and early HD, with a view to validating these as potential outcome measures for use in future therapeutic trials. The four study sites of TRACK-ON are in London, Paris, Leiden and Vancouver. TRACK-On will continue to follow the premanifest and control groups from TRACK-HD for an additional 24 months and will assess a number of new imaging modalities and clinical outcome measures.
A Clinical Research Fellowship is available for a medical graduate with an interest in neurology or psychiatry to work under the direction of Dr. Blair R. Leavitt, based in the Department of Medical Genetics and the Division of Neurology, Department of Medicine (associate) at the University of British Columbia (UBC) in Vancouver, Canada.
The work will be in the field of Huntington’s disease, which is an inherited neurodegenerative disorder. The project is a clinical translational project, and is suitable for those seeking a career in clinical neuroscience. The working environment is collective and multidisciplinary. Enthusiasm, ability to be self-organised, an enquiring mind, vision and good clinical skills will all be necessary. The candidate will need to have good computer skills and be able to pick up mathematical statistical concepts.
Further information ubc-trackon-neurology-fellow-mar2012